No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
UNITED KINGDOM — GSK’s myelofibrosis therapy, Ojjaara, also known as momelotinib, has received the coveted stamp of approval from the US Food and Drug Administration (FDA). This development marks a…
Read More
INDIA – Biocon Generics Inc., a wholly-owned subsidiary of Biocon, has acquired Eywa Pharma Inc.’s oral solid dosage manufacturing facility in the United States in a deal valued at US$7.7…
Read More
SWITZERLAND — Roche’s eagerly awaited subcutaneous version of its groundbreaking cancer immunotherapy Tecentriq may not receive its anticipated FDA decision on time. The FDA was set to deliver a verdict…
Read More
USA — In a groundbreaking move, the U.S. Food and Drug Administration (FDA) has given its nod to Tyruko (natalizumab-sztn), a biosimilar designed as a counterpart to Biogen’s Tysabri (natalizumab)…
Read More
USA — In a bid to uphold patient safety, Medtronic’s recent recall of hemodialysis catheters has been classified as a Class I event by the U.S. Food and Drug Administration…
Read More
USA —The Food and Drug Administration (FDA) has granted accelerated approval to Pfizer’s groundbreaking drug, Elrexfio. This momentous decision marks the third of its kind, positioning Elrexfio as a beacon…
Read More
USA —Biotechnology frontrunner Arcellx has received the green light from the Food and Drug Administration (FDA) to recommence a pivotal clinical trial involving a pioneering cell therapy for multiple myeloma.…
Read More
USA — GE HealthCare, a prominent US healthcare technology company, has secured a significant milestone with the US Food and Drug Administration (FDA) granting 510(k) approval for its groundbreaking Portrait…
Read More
USA —US-based medical innovator Boston Scientific has achieved a monumental feat with the US Food and Drug Administration (FDA) granting approval for the POLARx Cryoablation System. This innovative system stands…
Read More
USA — Johnson & Johnson has secured the coveted FDA approval for Akeega, a pioneering combination tablet poised to redefine the landscape of metastatic castration-resistant prostate cancer (mCRPC) treatment in…
Read More